BA.2.75 like a dark horse.
getty
Far from concluding, the Covid pandemic seems to be picking up speed with new variants. The BA.5 variant is spreading rapidly in Europe and North America, potentially infecting as many or more people as the original Omicron virus from which it is derived. A second variant, BA.2.75, has been detected in India and is increasing rapidly. We have previously described BA.4 and BA.5; here, we focus on the novel BA.2.75.
The Omicron BA.1 variant emerged in late 2021 with substantial genetic and virological differences. BA.1 was rapidly followed by the genetically different descendant BA.2. Figure 1 indicates the initial increase in BA.1, followed rapidly by BA.2. These accounted for most cases during the winter months of early 2022, when confirmed cases in the United States reached a maximum of one million per day. BA.4 and BA.5, which are very similar, are derived from BA.2, as are BA.2.75, albeit independently. There is no relationship between Omicron BA.1 and the other major variants, Alpha, Beta, Gamma, Delta, and so on. BA.4 / BA.5 is the dominant strain of Covid-19 today, and we believe that BA.2.75 can be joined. they.
FIGURE 1: BA.2.75 was derived independently of BA.2, differing significantly from BA.4 and BA.5.
ACCESS Health International
FIGURE 2: Cases in the United States designated by variant type.
Thorn
Later variants of Omicron, such as the currently dominant BA.4 and BA.5 strains, appear to be able to reinfect those previously infected with an earlier strain. Those infected with BA.1 were susceptible to BA.2, and so on. One report indicates that BA.5 was 14.3 to 16.8 times more resistant to Evusheld and Sotrovimab antibody treatments than previous variants. This resistance, in addition to new mutations, is likely related to sensitivity to a membrane protease, TMPRSS2, which is associated with cell membrane infectivity. BA.5 has a higher sensitivity to the TMPRSS2 Nafamostat inhibitor, meaning that BA.5 is slightly less infectious compared to BA.1 and BA.2, but could be more virulent and elusive immune, similar to the 2021 Delta variant.
FIGURE 3: (A) Change in linear regression between virus infectivity and diagnostic Ct PCR values … [+] provides a measure of the use of TMPRSS2 by individual variants (BD) Primary nasopharyngeal swabs were used to inoculate the HAT-24 cell line. Crops of (B) AY39.1 (one of the last Delta lineages detected), (C) BA.2 and (D) BA.5 images 72 hours after infection. (D) Infectivity for BA.2 and BA.5. (F) Virion particle count for three early clade variants (A.2.2, Beta, and Delta) and three Omicron sublinings (G) Diagram showing the effect of the TMPRSS2 Nafamostat inhibitor on input from the virus to the cell membrane. (H) The efficiency of TMPRSS2 use by the virus.
Aggarwal et al.
The latest in Omicron’s line of variants is BA.2.75, which has a different set of Spike mutations in addition to those found in BA.2, BA.4, BA.5 and other non-protein mutations. Spike, indicating that it was independently derived from BA.2.
BA.4 and BA.5 are very similar, differing only by a few mutations in the structural proteins N and M, the nonstructural protein NSP4 and the accessory proteins Orf6 and Orf7b, as described in a previous discussion (figure 3). These differences appear to give BA.5 a replication advantage, surpassing BA.4 in North America and Europe (Figure 2). Both silent and altered amino acid mutations in the Orf1ab replication complex, structural proteins, and accessory genes may increase SARS-CoV-2 viral fitness. It remains to be determined which mutation gives BA.5 the replication advantage it possesses.
FIGURE 4: Non-Spike Protein Mutations in BA.4 and BA.5
Dr. Tuli de l’Olivera
BA.2.75 is still very new. It was recently discovered in India, followed by ten countries shortly afterwards. The World Health Organization has already warned about BA.2.75 and continues to monitor the variant as it spreads to more regions of the world. Although confirmed cases due to BA.2.75 are relatively low, the numbers are expected to increase in the coming weeks.
BA.2.75 is not only a derivative of BA.2, but is different from BA.4 and BA.5.
FIGURE 5: Comparison of the Venn diagram of the BA.4 / BA.5 mutations versus BA.2.75. The ones on the left are … [+] only BA.4 and / or BA.5, those on the right are unique to BA.2.75, and those in the middle are shared between the two strains.
ACCESS Health International
Spike is the most mutated protein in the Omicron family of variants. This pattern is applied with BA.2.75. There are 36 mutated amino acids in the Spike BA.2.75 protein. Some early variants, such as Alpha, did not even carry 36 amino acid mutations in their entire genome. BA.2.75 has this amount in the Spike protein, which accounts for approximately 10% of the SARS-CoV-2 genome.
FIGURE 6: BA.2.75 Spike protein mutations. Those in red are in BA.2.75. The blue ones are … [+] only BA.2.75, that is, they are not in BA.2. The only mutation highlighted in green indicates that the position was reversed from Q493R to Q493 at BA.2.75. Black ones are not found in BA.2.75 or BA.2 but are found in other Omicron strains.
ACCESS Health International
Unique mutations in the Spike BA.2.75 protein are isolated at the N-terminal and receptor-binding domains. These are regularly the most mutated regions of the virus, as they are typical targets for neutralizing antibodies derived from infections, vaccines, and monoclonal treatments, meaning that mutations can allow the virus to overcome neutralization. These regions also play an important role in virus transmissibility, talking about how later variants become more infectious.
New additions fall into two categories: new mutations and reversions. We only find a reversal to BA.2.75, which is Q493. At BA.2, this position was mutated from glutamine to arginine (Q493R), a common mutation in circulating variants throughout the pandemic. Reversals are uncommon, as a mutation often confers some virological advantage over the original amino acid. However, this reversal may interact in a complementary manner with a new single mutation to confer a more significant advantage than Q493R alone might have.
Aside from reversal, there are eight mutations in BA.2.75 Spike that are unique to BA.2. In addition, all but eight mutations (K147E, W152R, F157L, I210V, G257S, G339H, and N460K) are uncommon in any previous variant of concern or interest.
We observe that F157L was previously detected in a smaller African strain A.23.1. Mutations occur at position I210 in African strains A.30 and French strains B.1.640, but at different mutations (I210N and I210T, respectively). In addition, the W152 position is mutated to the 2021 Epsilon strain, but to W152C.
Having such unique mutations at this stage of the pandemic when the virus has mutated into hundreds, even thousands of competing strains is amazing. These mutations are likely to keep health officials on high alert, as a large number of new mutations could indicate increased transmissibility or immune evasion if the variant ignites like its predecessor.
The new lineage also has five new additions outside of the Spike protein. Four are found in the replication-transcription complex Orf1ab, and the last in the envelope protein.
FIGURE 7: Mutations in BA.2.75 outside the Spike protein. Those in red are in BA.2.75. Those of … [+] blues are unique to BA.2.75, meaning they are not in BA.2. Black ones are not found in BA.2.75 or BA.2 but are found in other Omicron strains.
ACCESS Health International
Two of the unique mutations, S403L and P822S, are found in NSP3. This protein is involved in the formation of the structure of the replication compartment of double-membrane vesicles. It also inhibits interferon activity by directly dividing IRF3 and antagonizing MDA5 activation. Therefore, these mutations could be involved in virus replication and immune evasion activities.
In addition, we observed N118S in NSP8, G671S in NSP12, and T11A in the envelope protein. NSP12 is the RNA polymerase that drives viral replication and transcription, while NSP8 is a structural cofactor for this machinery. Wrapping is involved in viral assembly, budding, and viral porin activity. More research is needed on these unique mutations to determine their exact benefits, but they are likely to be involved in these processes. You can read more about the functions of each protein in our book Natural Immunity.
There may be several mutations that do not modify the amino acids in the coding sequence, known as synonymous mutations, but we do not have access to these at this time.
Even as we write this article, the Omicron family is constantly evolving. In addition to BA.2.75, recent reports from India suggest that there are accompanying lineages BA.2.74 and BA.2.76 circulating simultaneously with BA.2.75. At the moment, the exact sequences cannot be seen in the SARS-CoV-2 GISAID database, although researchers suggest that they share the same Spike protein, implying that the differences are outside the Spike of the same as BA.2.75 differs from the previous variants.
In short, having just recovered from the first BA.1 and BA.2 Omicron wave earlier this year, as well as the BA.2.12.1 wave in the United States and elsewhere, the world is facing now to two additional waves. variants, which individually or collectively can overcome the first wave in magnitude. In the UK epidemic alone, infections increased by several hundred thousand in previous weeks due to new strains. If the U.S. were to face similar increases, daily rates could be in the millions, surpassing the peak of the Omicron wave in mid-January. It remains to be seen the impact of BA.5 and BA.2.75 on health, hospitalization and death outcomes. All countries except China have abandoned public mitigation measures, namely the Covid …